SANOFI INDIA
|
The Current P/E Ratio of SANOFI INDIA is 36.48.
Share Price | ₹6,000.0 | Apr 03,2025 |
Market Cap | ₹13,799.9 Cr | |
Earnings-TTM | ₹378.3 Cr | TTM-Standalone Results |
Price/Earnings | 36.48x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SANOFI INDIA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹13,799.9 Cr] as on Apr 03,2025
(/) Earnings [ ₹378.3 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 36.48x ]
Thus, for SANOFI INDIA , the investors are currently willing to pay 36.48 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SANOFI INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SANOFI INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of SANOFI INDIA
PE Ratio Performance Analysis for SANOFI INDIA
- SANOFI INDIA 's p/e ratio for fiscal years ending Dec2023 to Dec2019 averaged 30.14x.
- SANOFI INDIA 's operated at median p/e ratio of 30.76x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SANOFI INDIA 's p/e ratio peaked in Dec2020 at 40.06x.
- SANOFI INDIA 's p/e ratio hit its five-year low in Dec2021 of 19.22x.
How does SANOFI INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SANOFI INDIA | 378.30 | 36.48 | 13,799.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.98 | 424,706.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 73.99 | 152,946.0 |
CIPLA LTD | 5,000.43 | 24.15 | 120,751.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 59.07 | 109,988.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 17.70 | 96,066.7 |
MANKIND PHARMA LTD | 2,050.73 | 48.85 | 100,168.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.75 | 90,666.7 |
LUPIN LTD | 2,892.10 | 33.07 | 95,627.5 |
AUROBINDO PHARMA LTD | 3,500.25 | 19.51 | 68,305.2 |
ABBOTT INDIA LTD | 1,334.46 | 47.68 | 63,621.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SANOFI INDIA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.70x |
Max industry PE | 73.99x |
Median industry PE | 36.48x |
Average industry PE | 37.93x |
You may also like the below Video Courses